Dr. Reddy’s Laboratories Ltd. ADR (NYSE: RDY) is -11.78% lower on its value in year-to-date trading and has touched a low of $12.26 and a high of $16.89 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The RDY stock was last observed hovering at around $13.40 in the last trading session, with the day’s gains setting it 0.53%.
Currently trading at $13.93, the stock is 1.78% and 4.77% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.35 million and changing 3.96% at the moment leaves the stock -5.31% off its SMA200. RDY registered -2.59% loss for a year compared to 6-month loss of -8.36%.
The stock witnessed a 9.60% gain in the last 1 month and extending the period to 3 months gives it a 0.87%, and is 0.43% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.38% over the week and 1.69% over the month.
Dr. Reddy’s Laboratories Ltd. ADR (RDY) has around 27048 employees, a market worth around $11.61B and $3.85B in sales. Current P/E ratio is 17.39 and Fwd P/E is 21.20. Profit margin for the company is 17.32%. Distance from 52-week low is 13.62% and -17.53% from its 52-week high. The company has generated returns on investments over the last 12 months (16.71%).
with sales reaching $83.7B over the same period.The EPS is expected to grow by 2.84% this year, but quarterly earnings will post 15.83% year-over-year. Quarterly sales are estimated to grow 18.17% in year-over-year returns.
Dr. Reddy’s Laboratories Ltd. ADR (RDY) Top Institutional Holders
The shares outstanding are 833.11M, and float is at 833.09M with Short Float at 1.79%.
The top institutional shareholder in the company is ROBECO INSTITUTIONAL ASSET MANAGEMENT B.V. with over 2.07 million shares valued at $157.65 million. The investor’s holdings represent 1.2406% of the RDY Shares outstanding. As of 2024-06-30, the second largest holder is ROYAL BANK OF CANADA with 2.06 million shares valued at $156.61 million to account for 1.2325 of the shares outstanding. The other top investors are MORGAN STANLEY which holds 2.03 million shares representing 1.2171% and valued at over $154.67 million, while RENAISSANCE TECHNOLOGIES LLC holds 1.1964 of the shares totaling 2.0 million with a market value of $152.04 million.
Dr. Reddy’s Laboratories Ltd. ADR (RDY) Insider Activity
#####
